| Filed | Form | Items | Signal | Score | Summary | Link |
|---|---|---|---|---|---|---|
| 2026-05-06 20:30 | 8-K | ["2.02", "9.01"] | other | 0.05 | Routine Q1 2026 earnings announcement with no M&A-related language or signals. | SEC · detail |
| 2026-05-04 09:12 | 8-K | ["1.01", "2.01", "5.03"] | merger agreement | 1.00 | Gyre Therapeutics completed acquisition of Cullgen Inc. for ~$300M in all-stock merger on May 4, 2026. | SEC · detail |